Cullinan Therapeutics Inc (CGEM)
15.61
-0.18
(-1.14%)
USD |
NASDAQ |
Nov 14, 10:21
Cullinan Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2021
--
Maximum
Mar 2021
--
Average
--
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.4322 |
| IGC Pharma Inc | 0.0173 |
| NovaBay Pharmaceuticals Inc | -1.128 |
| Protalix BioTherapeutics Inc | 0.7145 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 681.22M |
| Total Liabilities (Quarterly) | 25.00M |
| Shareholders Equity (Quarterly) | 656.22M |